Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ciro Celsa

Showing results (11-20 of 115) with videos related to

Pageof 12
Sort By:
Recenti Progressi in Medicina|January 23, 2019
Direct-acting antiviral agents and risk of hepatocellular carcinoma: is it still a clinical dilemma?Giuseppe Cabibbo, Margherita Rossi, Ciro Celsa, et al.
Hepatobiliary Surgery and Nutrition|February 12, 2021
Biliary complications after liver transplantation: current perspectives and future strategiesBianca Magro, Matteo Tacelli, Alessandra Mazzola, et al.
International Journal of Molecular Sciences|November 14, 2019
The Burden of Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease: Screening Issue and Future PerspectivesGrazia Pennisi, Ciro Celsa, Antonina Giammanco, et al.
Cancer Letters|May 18, 2026
Hepatic Decompensation: A Missing Endpoint in Advanced Hepatocellular Carcinoma TrialsGiuseppe Cabibbo, Ciro Celsa, Simona Restuccia, et al.
International Journal of Environmental Research and Public Health|November 10, 2019
Pharmacological Therapy of Non-Alcoholic Fatty Liver Disease: What Drugs Are Available Now and Future PerspectivesGrazia Pennisi, Ciro Celsa, Federica Spatola, et al.
Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A|July 16, 2020
Sicily Network for Liver Cancer: A Multidisciplinary Network Model for the Management of Primary Liver TumorsCiro Celsa, Giuseppe Cabibbo, Duilio Pagano, et al.
Journal of Hepatology|August 4, 2025
Establishing hepatic decompensation as a meaningful clinical outcome during systemic therapy for hepatocellular carcinomaGiuseppe Cabibbo, Ciro Celsa, Sherrie Bhoori, et al.
The Lancet. Oncology|September 29, 2022
COSMIC-312: mounting immunotherapy enigmas for hepatocellular carcinomaGiuseppe Cabibbo, Ciro Celsa, Antonio D'Alessio, et al.
Hepatobiliary Surgery and Nutrition|May 1, 2023
Immunotherapy for the treatment of hepatocellular carcinoma: finally in clinical practiceCiro Celsa, Lucia Cerrito, Leonardo Stella, et al.
Lancet (London, England)|July 27, 2023
The price and value of therapeutic synergy in liver cancerDavid J Pinato, Antonio D'Alessio, Ciro Celsa, et al.
Pageof 12

Showing results (11-20 of 115) with videos related to

Sort By:
Pageof 12
Recenti Progressi in Medicina|January 23, 2019
Direct-acting antiviral agents and risk of hepatocellular carcinoma: is it still a clinical dilemma?Giuseppe Cabibbo, Margherita Rossi, Ciro Celsa, et al.
Hepatobiliary Surgery and Nutrition|February 12, 2021
Biliary complications after liver transplantation: current perspectives and future strategiesBianca Magro, Matteo Tacelli, Alessandra Mazzola, et al.
International Journal of Molecular Sciences|November 14, 2019
The Burden of Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease: Screening Issue and Future PerspectivesGrazia Pennisi, Ciro Celsa, Antonina Giammanco, et al.
Cancer Letters|May 18, 2026
Hepatic Decompensation: A Missing Endpoint in Advanced Hepatocellular Carcinoma TrialsGiuseppe Cabibbo, Ciro Celsa, Simona Restuccia, et al.
International Journal of Environmental Research and Public Health|November 10, 2019
Pharmacological Therapy of Non-Alcoholic Fatty Liver Disease: What Drugs Are Available Now and Future PerspectivesGrazia Pennisi, Ciro Celsa, Federica Spatola, et al.
Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A|July 16, 2020
Sicily Network for Liver Cancer: A Multidisciplinary Network Model for the Management of Primary Liver TumorsCiro Celsa, Giuseppe Cabibbo, Duilio Pagano, et al.
Journal of Hepatology|August 4, 2025
Establishing hepatic decompensation as a meaningful clinical outcome during systemic therapy for hepatocellular carcinomaGiuseppe Cabibbo, Ciro Celsa, Sherrie Bhoori, et al.
The Lancet. Oncology|September 29, 2022
COSMIC-312: mounting immunotherapy enigmas for hepatocellular carcinomaGiuseppe Cabibbo, Ciro Celsa, Antonio D'Alessio, et al.
Hepatobiliary Surgery and Nutrition|May 1, 2023
Immunotherapy for the treatment of hepatocellular carcinoma: finally in clinical practiceCiro Celsa, Lucia Cerrito, Leonardo Stella, et al.
Lancet (London, England)|July 27, 2023
The price and value of therapeutic synergy in liver cancerDavid J Pinato, Antonio D'Alessio, Ciro Celsa, et al.
Pageof 12